SCHEMBL2779673

SCHEMBL2779673

O=C(O)c1cccnc1Oc1ccc(Cl)cc1Br

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.48
GPBAR1 Q8TDU6 3/20 0.46
NPC1 O15118 2/20 0.45
SMN1; SMN2 Q16637 6/20 0.45
LMNA P02545 2/20 0.45
ALDH1A1 P00352 4/20 0.44
GAA P10253 2/20 0.44
POLB P06746 1/20 0.44
MEN1 O00255 3/20 0.43
KMT2A Q03164 3/20 0.43
TDP1 Q9NUW8 2/20 0.43
MRGPRX4 Q96LA9 2/20 0.43
MAPT P10636 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
TSHR P16473 1/20 0.43
DHODH Q02127 1/20 0.43
CCR2 P41597 2/20 0.43
HPGD P15428 1/20 0.42
HTT P42858 1/20 0.42
CYP1A2 P05177 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2336929 0.86 MRGPRX4 (0.54) RAB9AGPBAR1SMN1; SMN2LMNAALDH1A1
SCHEMBL2780412 0.85 UGCG (0.49) RAB9AGPBAR1SMN1; SMN2LMNAALDH1A1
SCHEMBL2335696 0.85 GPBAR1 (0.60) RAB9AGPBAR1SMN1; SMN2LMNAALDH1A1
SCHEMBL2784871 0.84 TTR (0.50) RAB9AGPBAR1SMN1; SMN2LMNAALDH1A1
SCHEMBL2336930 0.84 LMNA (0.47) RAB9AGPBAR1SMN1; SMN2LMNAALDH1A1
SCHEMBL2779965 0.82 ROCK2 (0.46) RAB9AGPBAR1NPC1SMN1; SMN2LMNA
SCHEMBL2782226 0.81 TAS2R14 (0.48) RAB9ASMN1; SMN2LMNAALDH1A1MEN1
SCHEMBL2780235 0.79 PTGER1 (0.48) RAB9AGPBAR1SMN1; SMN2LMNAPOLB
SCHEMBL2779334 0.77 RAB9A (0.76) RAB9ASMN1; SMN2LMNAALDH1A1GAA
SCHEMBL2779685 0.77 MRGPRX4 (0.47) RAB9AGPBAR1SMN1; SMN2LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010091104-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS EXELIXIS, INC. (US) 2010-08-12 WO disclosed